Literature DB >> 26445680

Successful Treatment of Binge Eating Disorder With Combination Phentermine/Topiramate Extended Release.

Anna I Guerdjikova, Angela Fitch, Susan L McElroy1.   

Abstract

Entities:  

Year:  2015        PMID： 26445680      PMCID： PMC4560177          DOI： 10.4088/PCC.14l01708

Source DB:  PubMed          Journal:  Prim Care Companion CNS Disord        ISSN： 2155-7780


× No keyword cloud information.
  6 in total

1.  Topiramate for the treatment of binge eating disorder associated with obesity: a placebo-controlled study.

Authors:  Susan L McElroy; James I Hudson; Julie A Capece; Karen Beyers; Alan C Fisher; Norman R Rosenthal
Journal:  Biol Psychiatry       Date:  2007-01-29       Impact factor: 13.382

2.  The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication.

Authors:  James I Hudson; Eva Hiripi; Harrison G Pope; Ronald C Kessler
Journal:  Biol Psychiatry       Date:  2006-07-03       Impact factor: 13.382

Review 3.  Current and emerging drug treatments for binge eating disorder.

Authors:  Deborah L Reas; Carlos M Grilo
Journal:  Expert Opin Emerg Drugs       Date:  2014-01-25       Impact factor: 4.191

4.  Phentermine and topiramate extended release (Qsymia™): first global approval.

Authors:  Fiona Cameron; Glenn Whiteside; Kate McKeage
Journal:  Drugs       Date:  2012-10-22       Impact factor: 9.546

5.  Lateral hypothalamic injections of glutamate, kainic acid, D,L-alpha-amino-3-hydroxy-5-methyl-isoxazole propionic acid or N-methyl-D-aspartic acid rapidly elicit intense transient eating in rats.

Authors:  B G Stanley; L H Ha; L C Spears; M G Dee
Journal:  Brain Res       Date:  1993-06-04       Impact factor: 3.252

Review 6.  Anorectic drugs: use in general practice.

Authors:  D Craddock
Journal:  Drugs       Date:  1976       Impact factor: 9.546
  6 in total
  6 in total

Review 1.  Pharmacotherapy of eating disorders.

Authors:  Haley Davis; Evelyn Attia
Journal:  Curr Opin Psychiatry       Date:  2017-11       Impact factor: 4.741

Review 2.  Progress in Developing Pharmacologic Agents to Treat Bulimia Nervosa.

Authors:  Susan L McElroy; Anna I Guerdjikova; Nicole Mori; Francisco Romo-Nava
Journal:  CNS Drugs       Date:  2019-01       Impact factor: 5.749

Review 3.  Emerging Treatments in Eating Disorders.

Authors:  Michael Lutter
Journal:  Neurotherapeutics       Date:  2017-07       Impact factor: 7.620

4.  Combination Phentermine-Topiramate Extended Release for the Treatment of Binge Eating Disorder: An Open-Label, Prospective Study.

Authors:  Anna I Guerdjikova; Stephanie Williams; Thomas J Blom; Nicole Mori; Susan L McElroy
Journal:  Innov Clin Neurosci       Date:  2018-06-01

Review 5.  Clinical Considerations Regarding the Use of Obesity Pharmacotherapy in Adolescents with Obesity.

Authors:  Gitanjali Srivastava; Claudia K Fox; Aaron S Kelly; Ania M Jastreboff; Allen F Browne; Nancy T Browne; Janey S A Pratt; Christopher Bolling; Marc P Michalsky; Stephen Cook; Carine M Lenders; Caroline M Apovian
Journal:  Obesity (Silver Spring)       Date:  2019-02       Impact factor: 5.002

6.  Combining cognitive bias modification training (CBM) and transcranial direct current stimulation (tDCS) to treat binge eating disorder: study protocol of a randomised controlled feasibility trial.

Authors:  Gemma Gordon; Timo Brockmeyer; Ulrike Schmidt; Iain C Campbell
Journal:  BMJ Open       Date:  2019-10-22       Impact factor: 2.692
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.